Avita Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $347k | 32k | 10.72 |
| 2024-06-30 | $185k | 23k | 7.92 |
| 2024-03-31 | $165k | 10k | 16.03 |
| 2023-12-31 | $228k | 17k | 13.72 |
| 2023-09-30 | $249k | 17k | 14.61 |
| 2023-06-30 | $332k | 20k | 17.01 |
| 2023-03-31 | $93k | 6.6k | 13.99 |
| 2022-03-31 | $149k | 18k | 8.52 |
| 2021-12-31 | $814k | 68k | 11.96 |
| 2020-06-30 | $931k | 31k | 30.55 |